News

search close

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Read more

Relmada Therapeutics to Present at the Jefferies London Healthcare Conference

Read more

Relmada Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021

Read more

Relmada Therapeutics to Present Data at the Neuroscience Education Institute Congress

Read more

Relmada Therapeutics Provides Regulatory and Development Updates on Ongoing Late-Stage Clinical Program for REL-1017 for Treatment of Major Depressive Disorder

Read more

Relmada Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

Read more

Relmada Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Read more

Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Read more

Relmada Therapeutics to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10, 2021

Read more

Relmada Therapeutics Announces Top-Line Results of Study Evaluating REL-1017 vs Oxycodone for Abuse Potential

Read more